Replies to post #1969 on GTC Biotherapeutics (fka GTCB)

[ThomasS]

Dew, the inherent problem remains one of perception for the average patient, not for investors/academics/astute followers of technology such as yourself.
John Q Public would rather receive a "safe" plasma derivative, than one from a goat. imo, at least 90% of the time.
We would take the goat product without reservation, but, we have extensive exposure to an issue that the public does not. Of course, left solely in Practitioners hands, that percentage would likely decrease to 20%.

[jessellivermore]

I confess to being totally ignorant regarding Cerus and its Intercept Blood system for plasma. I am first of all intrigued by the name,Blood System for Plasma. Thats a little like saying a Milk System for Cream, or a Tree System for Leaves. My guess it would use some UV illumination system to eliminate the little critters. Asuming this is not merely a leucocyte filtration system.

What does it mean "it inactivates platelets and plasma" ??? That doesn't seem to be a good idea. Do they add a "compound" to increase the effect of the UV????

Finally the most important statement is the system is designed to lower the risk. Its got to be nigh on to impossible to eliminate all the viral types without turning the blood into gravy. Alot of them do pretty well intracellular.

Maybe someone can remember the US company who claimed they had a system similar to this back in the nineties.